Allergie

• AR101
• Olopatadine / mometasone
• Pinda extract

Chronische immuunziekten overig

• Abatacept^IND
• Belimumab^IND
• Budesonide
• Elobixibat
• Emapalumab
• Forigerimod
• Imlifidase
• Lanadelumab
• Lesinurad / allopurinol
• Naldemedine
• Teprasiran
• Teprotumumab
• Tocilizumab^IND
• Triamcinolone
• Voclosporin

Darmziekten

• Alicaforsen

  • Pouchitis
  • Ulcerative colitis^IND
• Remestemcel-L^IND
• Tenapanor
• Ustekinumab^IND

Hart- en vaatziekten

• Apremilast^IND
• Avacopan

• Rituximab

  • MabThera, in combination with glucocorticoids, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (Wegener’s) (GPA) and microscopic polyangiitis (MPA).^IND
  • Extension of indication to include the treatment of paediatric patients (aged ≥ 2 to <18 years old) with active polyangiitis (Wegener’s) (GPA) and microscopic polyangiitis (MPA).^IND

Huidziekten

• Baricitinib^IND
• Bimekizumab
• Clascoterone
• Crisaborole
• Dupilumab^IND
• Glycopyrronium tosylate
• KX2-391
• Nemolizumab
• Risankizumab
• Rituximab^IND

• Tapinarof

  • Adult Plaque Psoriasis
  • Atopische dermatitis
• Tildrakizumab
• Tralokinumab
• Trifarotene
• Upadacitinib^IND
• Ustekinumab^IND

Oogaandoeningen

• Eculizumab^IND
• Satralizumab

Reuma

• Abatacept^IND
• Filgotinib
• Ixekizumab^IND
• Olokizumab
• Secukinumab^IND

• Tocilizumab

  • Rheumatoid arthritis (RA), giant lymph node hyperplasia (Castlesman’s disease), polyarticular idioathic juvenile arthritis (PJIA) and systemic juvenile idiopathic arthritis (SJIA).^BS
  • RoActemra is indicated for the treatment of active systemic juvenile idiopathic arthritis (sJIA) in patients 1 year of age and older, who have responded inadequately to previous therapy with NSAIDs and systemic corticosteroids. RoActemra can be given as monotherapy (in case of intolerance to MTX or where treatment with MTX is inappropriate) or in combination with MTX.^IND
• Upadacitinib